These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 26464663)
1. Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway. Zhu Q; Liang X; Dai J; Guan X Int J Clin Exp Pathol; 2015; 8(8):9175-81. PubMed ID: 26464663 [TBL] [Abstract][Full Text] [Related]
2. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X; Li CY; Han P; Xu XY Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835 [TBL] [Abstract][Full Text] [Related]
4. ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway. Li F; Gu F; Li Q; Zhai C; Gong R; Zhu X J Biochem Mol Toxicol; 2021 May; 35(5):e22726. PubMed ID: 33491326 [TBL] [Abstract][Full Text] [Related]
5. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. Li YJ; Wang Y; Wang YY J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801 [TBL] [Abstract][Full Text] [Related]
7. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L; Zhang J; Fan Y; Li Y Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173 [TBL] [Abstract][Full Text] [Related]
8. MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K/AKT/mTOR pathway. Wang W; Zhang J; Fan Y; Zhang L Cell Cycle; 2022 Jul; 21(14):1491-1501. PubMed ID: 35416128 [TBL] [Abstract][Full Text] [Related]
9. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway. Gong T; Cui L; Wang H; Wang H; Han N J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734 [TBL] [Abstract][Full Text] [Related]
11. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907 [TBL] [Abstract][Full Text] [Related]
12. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression. Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225 [TBL] [Abstract][Full Text] [Related]
13. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling. Xu X; Jiang J; Yao L; Ji B Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267 [TBL] [Abstract][Full Text] [Related]
14. CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway. Wang RY; Chen XW; Zhang WW; Jiang F; Liu MQ; Shen XB Mol Med Rep; 2020 Feb; 21(2):842-850. PubMed ID: 31974627 [TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway. Wang N; Feng T; Liu X; Liu Q Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070 [TBL] [Abstract][Full Text] [Related]
16. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. Zhang S; Wang M; Li Q; Zhu P Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412 [TBL] [Abstract][Full Text] [Related]
17. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290 [TBL] [Abstract][Full Text] [Related]
18. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo. Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316 [TBL] [Abstract][Full Text] [Related]
19. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway. Lin Q; Chen H; Zhang M; Xiong H; Jiang Q Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003 [TBL] [Abstract][Full Text] [Related]
20. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation. Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]